SCHEMBL9051226

SCHEMBL9051226

N#C[C@@H]1CSCN1C(=O)[C@H]1NCC(=S)C1C(=O)C[C@H]1CCc2ccccc2C1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PREP P48147 19/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9050173 1.00 PREP (0.52) PREP
SCHEMBL9049564 0.95 PREP (0.49) PREP
SCHEMBL9050422 0.92 PREP (0.47) PREP
SCHEMBL9051115 0.92 PREP (0.47) PREP
SCHEMBL9049179 0.88 PREP (0.43) PREP
SCHEMBL9048068 0.86 PREP (0.44) PREP
SCHEMBL8152371 0.86 PREP (0.61) PREP
SCHEMBL9047940 0.86 PREP (0.61) PREP
SCHEMBL9045355 0.85 PREP (0.42) PREP
SCHEMBL9049633 0.85 PREP (0.42) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed